# Dabigatran etexilate

NDC: 43598-641
Generic name: Dabigatran etexilate
Labeler / Manufacturer: Dr.Reddys Laboratories Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250228

FDA application: ANDA208048

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43598-641"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43598-641
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a608e019-db9a-d6fb-cd0d-cecc1351a2b1